# Filing Detail

Form DRS - Draft Registration Statement:
SEC Accession No. 0001213900-23-098831
Filing Date
2023-12-27
Accepted
2023-12-27 15:15:59
Documents
8

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | filename1.htm | DRS | 4015493
2 | GRAPHIC | tanbio_logo.jpg | GRAPHIC | 53835
3 | GRAPHIC | tflowchart_001.jpg | GRAPHIC | 363865
4 | GRAPHIC | timage_002.jpg | GRAPHIC | 17105
5 | GRAPHIC | timage_005.jpg | GRAPHIC | 411207
6 | GRAPHIC | timage_006.jpg | GRAPHIC | 626201
7 | GRAPHIC | timage_007.jpg | GRAPHIC | 17129
8 | GRAPHIC | timage_008.jpg | GRAPHIC | 22850
| Complete submission text file | 0001213900-23-098831.txt |  | 6100369

Mailing Address FRIEDRICH-EBERT-ANLAGE 49 FRANKFURT AM MAIN 2M 60308
Business Address FRIEDRICH-EBERT-ANLAGE 49 FRANKFURT AM MAIN 2M 60308 4916096247281
Anbio Biotechnology (Filer) CIK: 0001982708 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-07031 | Film No.: 231517689
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)